HK1092463A1 - Substituted dihydrochinazolines having antiviral properties - Google Patents

Substituted dihydrochinazolines having antiviral properties

Info

Publication number: HK1092463A1
Authority: HK; Hong Kong
Prior art keywords: dihydrochinazolines; substituted; antiviral properties; antiviral; properties
Prior art date: 2003-05-02

Application number

HK06112993.6A

Other languages

English (en)

Inventor

Tobias Wunberg

Judith Baumeister

Ulrich Betz

Mario Jeske

Thomas Lampe

Susanne Nikolic

Juergen Reefschlaeger

Rudolf Schohe-Loop

Frank Suessmeier

Holger Zimmermann

Rolf Grosser

Kerstin Henninger

Guy Hewlett

Joerg Keldenich

Dieter Lang

Peter Nell

Original Assignee

Aicuris Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2006-11-27

Publication date

2007-02-09

2006-11-27 Application filed by Aicuris Gmbh filed Critical Aicuris Gmbh

2007-02-09 Publication of HK1092463A1 publication Critical patent/HK1092463A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

HK06112993.6A 2003-05-02 2006-11-27 Substituted dihydrochinazolines having antiviral properties HK1092463A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10319612A DE10319612A1 (de)	2003-05-02	2003-05-02	Substituierte Dihydrochinazoline
PCT/EP2004/004103 WO2004096778A1 (de)	2003-05-02	2004-04-17	Substituierte dihydrochinazoline mit antiviralen eigenschaften

Publications (1)

Publication Number	Publication Date
HK1092463A1 true HK1092463A1 (en)	2007-02-09

Family

ID=33305099

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK06112993.6A HK1092463A1 (en)	2003-05-02	2006-11-27	Substituted dihydrochinazolines having antiviral properties

Country Status (39)

Country	Link
US (4)	US7196086B2 (xx)
EP (1)	EP1622880B3 (xx)
JP (1)	JP4733631B2 (xx)
KR (1)	KR100927063B1 (xx)
CN (1)	CN100393706C (xx)
AR (1)	AR044078A1 (xx)
AT (1)	ATE355280T1 (xx)
AU (1)	AU2004233978B2 (xx)
BR (1)	BRPI0410029B8 (xx)
CA (1)	CA2524069C (xx)
CL (1)	CL2004000930A1 (xx)
CO (1)	CO5700764A2 (xx)
CY (2)	CY1106476T1 (xx)
DE (2)	DE10319612A1 (xx)
DK (1)	DK1622880T6 (xx)
EC (1)	ECSP056138A (xx)
EG (1)	EG25273A (xx)
ES (1)	ES2284007T7 (xx)
FR (1)	FR18C1029I2 (xx)
HK (1)	HK1092463A1 (xx)
HN (1)	HN2004000146A (xx)
HU (2)	HUS1800018I1 (xx)
IL (1)	IL171513A (xx)
MA (1)	MA27794A1 (xx)
MX (1)	MXPA05011707A (xx)
MY (1)	MY144616A (xx)
NL (1)	NL300933I2 (xx)
NO (2)	NO333265B3 (xx)
NZ (1)	NZ543317A (xx)
PE (1)	PE20050145A1 (xx)
PL (1)	PL1622880T6 (xx)
PT (1)	PT1622880E (xx)
RU (1)	RU2360912C2 (xx)
SI (1)	SI1622880T1 (xx)
TW (1)	TWI335912B (xx)
UA (1)	UA82519C2 (xx)
UY (1)	UY28294A1 (xx)
WO (1)	WO2004096778A1 (xx)
ZA (1)	ZA200508710B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10319612A1 (de)	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de) *	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) *	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
DE102004022672A1 (de)	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
DE102005027517A1 (de)	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
DE102011101446A1 (de) *	2011-05-10	2012-11-15	Aicuris Gmbh & Co. Kg	Herstellung von "Dense Bodies" (DB)
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101659A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101673A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
HUE043721T2 (hu) *	2013-06-19	2019-09-30	Aicuris Anti Infective Cures Gmbh	Amorf letermovir és szilárd gyógyászati készítményei orális adagolásra
WO2015088931A1 (en) *	2013-12-12	2015-06-18	Merck Sharp & Dohme Corp.	Process for making substituted quinazoline compounds
WO2017091453A1 (en) *	2015-11-24	2017-06-01	Merck Sharp & Dohme Corp.	Novel processes for making substituted quinazoline compounds using hydrogen bonding catalysts
ES2882531T3 (es) *	2016-08-08	2021-12-02	Phaeno Therapeutics Co Ltd	Compuesto anti-virus CMVH
ES2971079T3 (es) *	2018-02-08	2024-06-03	Phaeno Therapeutics Co Ltd	Forma cristalina del compuesto 3,4-dihidrotieno[3,2-d]pirimidina y método de preparación del mismo
EP3527209A1 (en) *	2018-02-16	2019-08-21	UCB Biopharma SPRL	Pharmaceutical 6,5 heterobicyclic ring derivatives
JP7273951B2 (ja)	2018-09-12	2023-05-15	ノバルティスアーゲー	抗ウイルス性ピリドピラジンジオン化合物
KR20220070005A (ko)	2019-09-26	2022-05-27	노파르티스 아게	항바이러스성 피라졸로피리디논 화합물
UY39097A (es)	2020-02-27	2021-09-30	Aic246 Gmbh & Co Kg	Sal de potasio del ácido 2-[(4s)-8-fluoro-2-[4-(3- metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acético
AR121440A1 (es) *	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Un método de preparación de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio monohidrato, dicho compuesto y el uso del mismo para el tratamiento de infecciones virales
AR121438A1 (es)	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] e iones de sodio
AR121439A1 (es)	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Un método para producir una forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato
UY39099A (es)	2020-02-27	2021-08-31	Aic246 Gmbh & Co Kg	2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio y composiciones farmacéuticas del mismo
EP3906929A1 (en)	2020-05-08	2021-11-10	AiCuris GmbH & Co. KG	Letermovir for use in the prevention and the treatment of coronavirus infections
CA3189271A1 (en)	2020-08-17	2022-02-24	Girij Pal Singh	A precipitation process for amorphous letermovir
CN115403528A (zh) *	2021-05-27	2022-11-29	南京正大天晴制药有限公司	无定形3,4-二氢喹唑啉衍生物的制备方法
CN114031560B (zh) *	2021-11-16	2022-10-04	山东诚创蓝海医药科技有限公司	一种来特莫韦钠盐的制备方法
AR128035A1 (es)	2021-12-21	2024-03-20	Aic246 Ag & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] e iones de potasio
WO2023185597A1 (zh) *	2022-04-01	2023-10-05	上海迪赛诺化学制药有限公司	莱特莫韦中间体及其制备方法
CN115322157B (zh) *	2022-06-02	2023-12-05	浙江车头制药股份有限公司	来特莫韦中间体化合物及其制备方法和应用
CN117229223A (zh) *	2022-06-08	2023-12-15	苏州远智医药科技有限公司	一种杂环衍生物及其药物组合物、应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4320347A1 (de)	1993-06-19	1994-12-22	Boehringer Mannheim Gmbh	Quinazolin-Derivate und diese enthaltende Arzneimittel
US5854245A (en)	1996-06-28	1998-12-29	Merck & Co., Inc.	Fibrinogen receptor antagonists
DE19802437A1 (de)	1998-01-23	1999-07-29	Bayer Ag	Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
CA2321153A1 (en)	1998-02-17	1999-08-19	Timothy D. Cushing	Anti-viral pyrimidine derivatives
EP1172361A4 (en)	1999-04-19	2002-05-08	Shionogi & Co	SULFONAMIDE DERIVATIVES HAVING OXADIAZOLE CORES
DE19930075A1 (de)	1999-06-30	2001-01-04	Bayer Ag	Neue Amino- und Amidosulfonamide als antivirale Mittel
US6730682B2 (en)	2000-07-12	2004-05-04	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
AU2001283955B2 (en)	2000-07-31	2006-05-18	F. Hoffmann-La Roche Ag	Piperazine derivatives
EP1201765A3 (en) *	2000-10-16	2003-08-27	Axxima Pharmaceuticals Aktiengesellschaft	Cellular kinases involved in cytomegalovirus infection and their inhibition
JP4480941B2 (ja)	2001-04-19	2010-06-16	アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト	抗ウイルス剤としての新規アリールスルホンアミド
DE10138578A1 (de)	2001-08-06	2003-02-27	Bayer Ag	Heterocyclylarylsulfonamide
DE10251914A1 (de)	2002-11-08	2004-05-19	Bayer Ag	Substituierte Chinazoline
DE10319612A1 (de)	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de)	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de)	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
KR100610731B1 (ko)	2004-02-24	2006-08-09	한국과학기술연구원	Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법
DE102004022672A1 (de)	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
BRPI0607306A2 (pt) *	2005-01-25	2009-08-25	Prolexys Pharmaceuticals Inc	derivados de quinoxalina como agentes anti-tumor
DE102005027517A1 (de) *	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
CA2614443C (en)	2005-07-21	2011-03-22	F. Hoffmann-La Roche Ag	Pyrido [2,3-d] pyrimidine-2,4-diamine compounds as ptp1b inhibitors
DE102006009928A1 (de)	2006-03-03	2007-09-06	Aicuris Gmbh & Co. Kg	Substituierte Arylsulfonamide
DE102012101673A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101659A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
HUE043721T2 (hu) *	2013-06-19	2019-09-30	Aicuris Anti Infective Cures Gmbh	Amorf letermovir és szilárd gyógyászati készítményei orális adagolásra

2003
- 2003-05-02 DE DE10319612A patent/DE10319612A1/de not_active Withdrawn
2004
- 2004-04-17 DE DE502004003052T patent/DE502004003052D1/de not_active Expired - Lifetime
- 2004-04-17 AT AT04728119T patent/ATE355280T1/de active
- 2004-04-17 NZ NZ543317A patent/NZ543317A/en not_active IP Right Cessation
- 2004-04-17 ES ES04728119.1T patent/ES2284007T7/es active Active
- 2004-04-17 KR KR1020057020720A patent/KR100927063B1/ko active IP Right Grant
- 2004-04-17 PT PT04728119T patent/PT1622880E/pt unknown
- 2004-04-17 AU AU2004233978A patent/AU2004233978B2/en active Active
- 2004-04-17 BR BRPI0410029A patent/BRPI0410029B8/pt active IP Right Grant
- 2004-04-17 RU RU2005137276/04A patent/RU2360912C2/ru active
- 2004-04-17 CN CNB2004800119284A patent/CN100393706C/zh not_active Expired - Lifetime
- 2004-04-17 DK DK04728119.1T patent/DK1622880T6/da active
- 2004-04-17 JP JP2006505178A patent/JP4733631B2/ja not_active Expired - Lifetime
- 2004-04-17 UA UAA200511418A patent/UA82519C2/uk unknown
- 2004-04-17 MX MXPA05011707A patent/MXPA05011707A/es active IP Right Grant
- 2004-04-17 SI SI200430301T patent/SI1622880T1/sl unknown
- 2004-04-17 EP EP04728119.1A patent/EP1622880B3/de not_active Expired - Lifetime
- 2004-04-17 PL PL04728119T patent/PL1622880T6/pl unknown
- 2004-04-17 CA CA2524069A patent/CA2524069C/en not_active Expired - Lifetime
- 2004-04-17 WO PCT/EP2004/004103 patent/WO2004096778A1/de active IP Right Grant
- 2004-04-23 AR ARP040101391A patent/AR044078A1/es active IP Right Grant
- 2004-04-26 US US10/832,109 patent/US7196086B2/en not_active Ceased
- 2004-04-28 UY UY28294A patent/UY28294A1/es not_active IP Right Cessation
- 2004-04-29 HN HN2004000146A patent/HN2004000146A/es unknown
- 2004-04-29 MY MYPI20041603A patent/MY144616A/en unknown
- 2004-04-30 PE PE2004000432A patent/PE20050145A1/es active IP Right Grant
- 2004-04-30 TW TW093112100A patent/TWI335912B/zh active
- 2004-04-30 CL CL200400930A patent/CL2004000930A1/es unknown
2005
- 2005-10-20 IL IL171513A patent/IL171513A/en active IP Right Grant
- 2005-10-27 ZA ZA2005/08710A patent/ZA200508710B/en unknown
- 2005-10-29 EG EGNA2005000688 patent/EG25273A/xx active
- 2005-11-01 EC EC2005006138A patent/ECSP056138A/es unknown
- 2005-11-02 CO CO05111848A patent/CO5700764A2/es active IP Right Grant
- 2005-11-08 MA MA28581A patent/MA27794A1/fr unknown
- 2005-11-30 NO NO20055649A patent/NO333265B3/no active Protection Beyond IP Right Term
2006
- 2006-11-27 HK HK06112993.6A patent/HK1092463A1/xx not_active IP Right Cessation
2007
- 2007-03-26 US US11/728,896 patent/US8513255B2/en active Active
- 2007-05-25 CY CY20071100709T patent/CY1106476T1/el unknown
2015
- 2015-04-09 US US14/682,512 patent/USRE46791E1/en active Active
2018
- 2018-04-17 NL NL300933C patent/NL300933I2/nl unknown
- 2018-04-21 HU HUS1800018C patent/HUS1800018I1/hu unknown
- 2018-06-15 HU HUS1800028C patent/HUS1800028I1/hu unknown
- 2018-06-29 CY CY2018019C patent/CY2018019I2/el unknown
- 2018-07-04 NO NO2018022C patent/NO2018022I1/no unknown
- 2018-07-06 FR FR18C1029C patent/FR18C1029I2/fr active Active
2020
- 2020-07-21 US US16/934,363 patent/USRE49698E1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1622880A1 (de)	2006-02-08
IL171513A (en)	2011-11-30
NO333265B3 (no)	2019-06-03
TW200510343A (en)	2005-03-16
KR20060009883A (ko)	2006-02-01
CN100393706C (zh)	2008-06-11
AU2004233978B2 (en)	2010-02-11
US8513255B2 (en)	2013-08-20
UY28294A1 (es)	2004-11-30
EG25273A (en)	2011-12-04
CY2018019I1 (el)	2018-12-12
MXPA05011707A (es)	2006-02-13
AU2004233978A1 (en)	2004-11-11
DK1622880T6 (da)	2018-06-18
NO333265B1 (no)	2013-04-22
RU2360912C2 (ru)	2009-07-10
HUS1800028I1 (hu)	2018-07-30
FR18C1029I1 (xx)	2018-08-17
EP1622880B1 (de)	2007-02-28
ES2284007T3 (es)	2007-11-01
USRE49698E1 (en)	2023-10-17
ATE355280T1 (de)	2006-03-15
JP2006525249A (ja)	2006-11-09
TWI335912B (en)	2011-01-11
CO5700764A2 (es)	2006-11-30
NO20055649D0 (no)	2005-11-30
HN2004000146A (es)	2008-06-24
DE502004003052D1 (de)	2007-04-12
HUS1800018I1 (hu)	2018-05-28
BRPI0410029A (pt)	2006-04-25
BRPI0410029B8 (pt)	2021-06-15
PL1622880T3 (pl)	2007-08-31
CY1106476T1 (el)	2012-01-25
SI1622880T1 (sl)	2007-08-31
MY144616A (en)	2011-10-14
ECSP056138A (es)	2006-04-19
AR044078A1 (es)	2005-08-24
FR18C1029I2 (fr)	2020-07-17
RU2005137276A (ru)	2006-07-27
US7196086B2 (en)	2007-03-27
NL300933I2 (nl)	2018-04-26
BRPI0410029B1 (pt)	2019-12-31
PL1622880T6 (pl)	2018-08-31
JP4733631B2 (ja)	2011-07-27
CA2524069C (en)	2011-11-08
US20050065160A1 (en)	2005-03-24
PE20050145A1 (es)	2005-05-22
MA27794A1 (fr)	2006-03-01
CL2004000930A1 (es)	2005-03-18
NO2018022I1 (no)	2018-07-04
US20070191387A1 (en)	2007-08-16
CA2524069A1 (en)	2004-11-11
DE10319612A1 (de)	2004-11-18
ES2284007T7 (es)	2018-06-20
DK1622880T3 (da)	2007-06-25
USRE46791E1 (en)	2018-04-17
UA82519C2 (uk)	2008-04-25
ZA200508710B (en)	2006-12-27
WO2004096778A1 (de)	2004-11-11
NO20055649L (no)	2006-01-31
CN1784390A (zh)	2006-06-07
EP1622880B3 (de)	2018-05-23
PT1622880E (pt)	2007-06-04
CY2018019I2 (el)	2018-12-12
KR100927063B1 (ko)	2009-11-13
NZ543317A (en)	2008-05-30

Publication	Publication Date	Title
HUS1800028I1 (hu)	2018-07-30	Antivirális tulajdonságú szubsztituált dihidrokinazolinok
TWI372050B (en)	2012-09-11	(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
ZA200603879B (en)	2010-01-27	Substituted indazole-O-glucosides
IL175490A0 (en)	2011-08-01	Substituted indazole-o-glucosides
ZA200603880B (en)	2010-01-27	Substituted indole-O-glucosides
EP1680131A4 (en)	2009-05-27	SUBSTITUTED INDOLE-O-GLUCOSIDES
DE502004011703D1 (en)	2010-11-11	N-heterocyclyl-phenylsubstituierte cyclische ketoenole
DE602004012071D1 (en)	2008-04-10	T-hilfe
DE602004020356D1 (en)	2009-05-14	Phenoxyessigsäurederivate
DE502004009243D1 (en)	2009-05-07	Spirocyclische cyclohexan-derivate
IL175809A0 (en)	2006-10-05	Diazaindole-dicarbonyl-piperazinyl antiviral agents
DE502004003476D1 (en)	2007-05-24	Standfuss
DE502004006683D1 (en)	2008-05-08	Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en)	2010-12-16	Nspritzventil
ZA200600430B (en)	2009-08-26	Substituted spirobenzazepines
DE502004004146D1 (en)	2007-08-02	Pyrazolverbindungen
DE112004002769D2 (en)	2006-11-09	Schienengeführtes transportsystem
DE502004011343D1 (en)	2010-08-12	Rotorspinnmaschine
DE602004012262D1 (en)	2008-04-17	Benzimidazolonverbindung
DE602004020525D1 (en)	2009-05-20	Imidazolderivate
DE502004012153D1 (en)	2011-03-10	Rotorspinnmaschine
DE10394343D2 (en)	2006-08-24	Berührungslose biometrische erkennung
GB0318094D0 (en)	2003-09-03	Novel combination
GB0325291D0 (en)	2003-12-03	Novel combination
DE602004009041D1 (en)	2007-10-31	Hydroxytetrahydronaphthalenylharnstoffderivate

Legal Events

Date	Code	Title	Description
2024-04-26	PE	Patent expired	Effective date: 20240416